Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

STAA vs LNTH vs MDT vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
STAA
STAAR Surgical Company

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$1.35B
5Y Perf.-29.7%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.92B
5Y Perf.+562.8%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-20.9%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%

STAA vs LNTH vs MDT vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
STAA logoSTAA
LNTH logoLNTH
MDT logoMDT
ISRG logoISRG
IndustryMedical - Instruments & SuppliesDrug Manufacturers - Specialty & GenericMedical - DevicesMedical - Instruments & Supplies
Market Cap$1.35B$5.92B$99.94B$161.07B
Revenue (TTM)$239M$1.55B$35.48B$10.58B
Net Income (TTM)$-80M$279M$4.61B$2.98B
Gross Margin75.6%60.5%61.9%66.3%
Operating Margin-33.3%18.8%17.9%30.5%
Forward P/E70.2x17.5x14.1x43.8x
Total Debt$38M$738K$28.52B$303M
Cash & Equiv.$153M$359M$2.22B$3.37B

STAA vs LNTH vs MDT vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

STAA
LNTH
MDT
ISRG
StockMay 20May 26Return
STAAR Surgical Comp… (STAA)10070.3-29.7%
Lantheus Holdings, … (LNTH)100662.8+562.8%
Medtronic plc (MDT)10079.1-20.9%
Intuitive Surgical,… (ISRG)100234.6+134.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: STAA vs LNTH vs MDT vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Intuitive Surgical, Inc. is the stronger pick specifically for growth and revenue expansion and profitability and margin quality. STAA also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
STAA
STAAR Surgical Company
The Momentum Pick

STAA is the clearest fit if your priority is momentum.

  • +40.3% vs ISRG's -15.4%
Best for: momentum
LNTH
Lantheus Holdings, Inc.
The Long-Run Compounder

LNTH is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 41.9% 10Y total return vs ISRG's 5.5%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
Best for: long-term compounding and sleep-well-at-night
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Lower P/E (14.1x vs 70.2x)
  • Beta 0.47 vs ISRG's 1.02
Best for: income & stability and defensive
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • PEG 2.01 vs MDT's 36.00
  • 20.5% revenue growth vs STAA's -23.7%
  • 28.2% margin vs STAA's -33.6%
Best for: growth exposure and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs STAA's -23.7%
ValueMDT logoMDTLower P/E (14.1x vs 70.2x)
Quality / MarginsISRG logoISRG28.2% margin vs STAA's -33.6%
Stability / SafetyMDT logoMDTBeta 0.47 vs ISRG's 1.02
DividendsMDT logoMDT3.6% yield; 36-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)STAA logoSTAA+40.3% vs ISRG's -15.4%
Efficiency (ROA)MDT logoMDT175.8% ROA vs STAA's -17.8%, ROIC 6.0% vs -13.2%

STAA vs LNTH vs MDT vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

STAASTAAR Surgical Company
FY 2024
Implantable Collamer Lenses
99.6%$313M
Other Surgical Products
0.4%$1M
LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

STAA vs LNTH vs MDT vs ISRG — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGSTAA

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 148.2x STAA's $239M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to STAA's -33.6%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$239M$1.5B$35.5B$10.6B
EBITDAEarnings before interest/tax-$71M$347M$9.4B$3.8B
Net IncomeAfter-tax profit-$80M$279M$4.6B$3.0B
Free Cash FlowCash after capex-$34M$372M$5.4B$2.8B
Gross MarginGross profit ÷ Revenue+75.6%+60.5%+61.9%+66.3%
Operating MarginEBIT ÷ Revenue-33.3%+18.8%+17.9%+30.5%
Net MarginNet income ÷ Revenue-33.6%+18.0%+13.0%+28.2%
FCF MarginFCF ÷ Revenue-14.4%+24.0%+15.2%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+18.1%+1.2%+8.8%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+47.8%+76.5%-11.9%+18.8%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MDT leads this category, winning 4 of 7 comparable metrics.

At 21.6x trailing earnings, MDT trades at a 63% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), ISRG offers better value at 2.65x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Market CapShares × price$1.3B$5.9B$99.9B$161.1B
Enterprise ValueMkt cap + debt − cash$1.2B$5.6B$126.2B$158.0B
Trailing P/EPrice ÷ TTM EPS-16.84x26.69x21.60x57.62x
Forward P/EPrice ÷ next-FY EPS est.70.16x17.52x14.13x43.84x
PEG RatioP/E ÷ EPS growth rate36.00x2.65x
EV / EBITDAEnterprise value multiple14.61x14.32x43.62x
Price / SalesMarket cap ÷ Revenue5.63x3.84x2.98x16.00x
Price / BookPrice ÷ Book value/share3.93x5.72x2.08x9.17x
Price / FCFMarket cap ÷ FCF16.73x19.28x64.67x
MDT leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

LNTH leads this category, winning 6 of 9 comparable metrics.

LNTH delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-23 for STAA. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MDT's 0.59x. On the Piotroski fundamental quality scale (0–9), MDT scores 6/9 vs STAA's 1/9, reflecting solid financial health.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-23.2%+24.3%+9.4%+16.9%
ROA (TTM)Return on assets-17.8%+12.4%+175.8%+14.8%
ROICReturn on invested capital-13.2%+30.6%+6.0%+15.0%
ROCEReturn on capital employed-11.2%+17.1%+7.5%+16.5%
Piotroski ScoreFundamental quality 0–91566
Debt / EquityFinancial leverage0.11x0.00x0.59x0.02x
Net DebtTotal debt minus cash-$115M-$358M$26.3B-$3.1B
Cash & Equiv.Liquid assets$153M$359M$2.2B$3.4B
Total DebtShort + long-term debt$38M$738,000$28.5B$303M
Interest CoverageEBIT ÷ Interest expense11.72x9.08x
LNTH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LNTH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $1,980 for STAA. Over the past 12 months, STAA leads with a +40.3% total return vs ISRG's -15.4%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs STAA's -26.1% — a key indicator of consistent wealth creation.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date+15.6%+35.3%-18.1%-19.3%
1-Year ReturnPast 12 months+40.3%+13.1%-2.8%-15.4%
3-Year ReturnCumulative with dividends-59.7%-4.0%-4.2%+49.6%
5-Year ReturnCumulative with dividends-80.2%+314.2%-27.7%+58.7%
10-Year ReturnCumulative with dividends+273.7%+4192.5%+26.5%+554.2%
CAGR (3Y)Annualised 3-year return-26.1%-1.4%-1.4%+14.4%
LNTH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than ISRG's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs MDT's 73.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5000.54x0.47x0.47x1.02x
52-Week HighHighest price in past year$30.81$93.00$106.33$603.88
52-Week LowLowest price in past year$15.64$47.25$77.16$427.84
% of 52W HighCurrent price vs 52-week peak+88.5%+97.8%+73.3%+75.1%
RSI (14)Momentum oscillator 0–10070.061.227.342.4
Avg Volume (50D)Average daily shares traded1.2M886K7.8M1.8M
Evenly matched — LNTH and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 1 of 1 comparable metric.

Analyst consensus: STAA as "Hold", LNTH as "Buy", MDT as "Buy", ISRG as "Buy". Consensus price targets imply 40.5% upside for MDT (target: $110) vs -15.9% for STAA (target: $23). MDT is the only dividend payer here at 3.57% yield — a key consideration for income-focused portfolios.

MetricSTAA logoSTAASTAAR Surgical Co…LNTH logoLNTHLantheus Holdings…MDT logoMDTMedtronic plcISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$22.95$101.00$109.50$622.60
# AnalystsCovering analysts15174955
Dividend YieldAnnual dividend ÷ price+3.6%
Dividend StreakConsecutive years of raises036
Dividend / ShareAnnual DPS$2.78
Buyback YieldShare repurchases ÷ mkt cap+0.5%+5.1%+3.2%+1.4%
MDT leads this category, winning 1 of 1 comparable metric.
Key Takeaway

MDT leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). LNTH leads in 2 (Profitability & Efficiency, Total Returns). 1 tied.

Best OverallLantheus Holdings, Inc. (LNTH)Leads 2 of 6 categories
Loading custom metrics...

STAA vs LNTH vs MDT vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is STAA or LNTH or MDT or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -23. 7% for STAAR Surgical Company (STAA). Medtronic plc (MDT) offers the better valuation at 21. 6x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Lantheus Holdings, Inc. (LNTH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — STAA or LNTH or MDT or ISRG?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

6x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Medtronic plc is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Intuitive Surgical, Inc. wins at 2. 01x versus Medtronic plc's 36. 00x.

03

Which is the better long-term investment — STAA or LNTH or MDT or ISRG?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +314. 2%, compared to -80. 2% for STAAR Surgical Company (STAA). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus MDT's +26. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — STAA or LNTH or MDT or ISRG?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

47β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 119% more volatile than MDT relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 59% for Medtronic plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — STAA or LNTH or MDT or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -23. 7% for STAAR Surgical Company (STAA). On earnings-per-share growth, the picture is similar: Medtronic plc grew EPS 30. 8% year-over-year, compared to -295. 1% for STAAR Surgical Company. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — STAA or LNTH or MDT or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -33. 6% for STAAR Surgical Company — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -19. 2% for STAA. At the gross margin level — before operating expenses — STAA leads at 73. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is STAA or LNTH or MDT or ISRG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Intuitive Surgical, Inc. (ISRG) is the more undervalued stock at a PEG of 2. 01x versus Medtronic plc's 36. 00x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Medtronic plc (MDT) trades at 14. 1x forward P/E versus 70. 2x for STAAR Surgical Company — 56. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.

08

Which pays a better dividend — STAA or LNTH or MDT or ISRG?

In this comparison, MDT (3.

6% yield) pays a dividend. STAA, LNTH, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is STAA or LNTH or MDT or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

47), 3. 6% yield). Both have compounded well over 10 years (MDT: +26. 5%, ISRG: +554. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between STAA and LNTH and MDT and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: STAA is a small-cap quality compounder stock; LNTH is a small-cap quality compounder stock; MDT is a mid-cap income-oriented stock; ISRG is a mid-cap high-growth stock. MDT pays a dividend while STAA, LNTH, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

STAA

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 45%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform STAA and LNTH and MDT and ISRG on the metrics below

Revenue Growth>
%
(STAA: 18.1% · LNTH: 1.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.